ArticleBMC infectious diseases2026
Early plasma exchange for severe fever with thrombocytopenia syndrome (SFTS)-associated encephalopathy and multi-organ dysfunction syndrome (MODS): a case report.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSevere fever with thrombocytopenia syndrome (SFTS) is a tick-borne viral disease caused by Dabie bandavirus, associated with high morbidity and mortality. Neurological complications such as encephalopathy are increasingly recognized and are linked to poor prognosis. No specific antiviral treatment is available, and management is mainly supportive. CASE PRESENTATION: We report a rare case of SFTS in a 72-year-old woman who developed acute encephalopathy and multi-organ dysfunction shortly after a wasp sting. The patient presented with thrombocytopenia, elevated liver enzymes, and central nervous system involvement, including seizures and coma. Next-generation sequencing and serological testing confirmed SFTS. Despite standard antiviral and supportive therapies, rapid deterioration prompted therapeutic plasma exchange (TPE) initiation. After two sessions of TPE, the patient showed significant clinical improvement, including recovery of consciousness, normalization of laboratory markers, and resolution of neurological symptoms.
conclusionThis case highlights the potential utility of early TPE in managing fulminant SFTS with central nervous system involvement. TPE may attenuate cytokine-mediated inflammation and improve outcomes in patients with severe Bunyavirus-associated encephalopathy. Further studies are warranted to standardize its use in this context. CLINICAL TRIAL: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.